All Cases

Emerging Markets

Designed a cardiovascular risk management program for private insurers in Mexico

Defining a go-to-market strategy that redefines a pharma company’s approach to the public sector in Mexico

Developed a roadmap to resolve specific access challenges for low-income patients in Mexico 

Developed comprehensive payer portfolio offerings, including services and payment strategies in several emerging markets, including the Middle East, Gulf Countries, Saudi Arabia and Latin America

Assessed new pain portfolio product lines, for potential update in the Middle East, Central America, and North Africa.

Constructed a value proposition and IMSS (Mexico) access plan for a novel multiple sclerosis (MS) therapy

Developed a value proposition for an EGFR-targeting biologic intended to be marked by a large international pharmaceutical company to present to IMSS in Mexico

Analyzed a market entry strategy for a large, global pharmaceutical company to ensure it aligned with expected capacity and could be supported by its expected economic impact

Developed a launch excellence plan, based on local market inputs for a global pharmaceutical company

Identification of emerging market launch scenarios with highest success probability for a large pharmaceutical company